China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)

Market Cap	16.13B +14.4%
Revenue (ttm)	4.07B -6.3%
Net Income	909.82M +13.1%
EPS	1.44 +13.2%
Shares Out	629.46M
PE Ratio	17.81
Forward PE	16.15
Dividend	1.38 (5.32%)
Ex-Dividend Date	n/a

Volume	4,294,933
Open	25.92
Previous Close	25.96
Day's Range	25.33 - 25.95
52-Week Range	21.05 - 27.83
Beta	0.02
Analysts	Strong Buy
Price Target	29.81 (+16.35%)
Earnings Date	Aug 21, 2026

About SHA:600750

China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsules, bezoar and snake gallbladder fritillaria liquid, and compound gold melon seed. It also provides health consumer and other products, such as nouris...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,352
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600750

Financial Performance

In 2025, SHA:600750's revenue was 4.22 billion, a decrease of -4.87% compared to the previous year's 4.44 billion. Earnings were 906.69 million, an increase of 15.03%.

Analyst Summary

According to 6 analysts, the average rating for 600750 stock is "Strong Buy." The 12-month stock price target is ¥29.81, which is an increase of 16.35% from the latest price.

Price Target

¥29.81

(16.35% upside)

Analyst Consensus: Strong Buy